Study dispels myth that cancer biopsies cause cancer spread
the ONA take:
According to a new study published in the journal Gut, researchers at the Mayo Clinic in Jacksonville, Florida, have found that cancer biopsies do not cause cancer to spread and that patients who underwent a biopsy had better outcomes than those who did not receive one.
For the study, researchers analyzed the Medicare data of over 2,000 patients with non-metastatic pancreatic cancer who underwent surgery for their disease. Of those, about approximately 500 had an ultrasound-guided fine needle aspiration, while the other 1,500 did not.
Results showed that during a median follow-up time of 21 months, 57% of those who received a biopsy and 76% of those that did not died. Fifty percent of those in the biopsy group compared with 64% of the non-biopsy group were found to have died as a result of pancreatic cancer.
Furthermore, the median overall survival in the biopsy group was 22 months versus 15 months in the non-biopsy group. The findings suggest that the minimally invasive fine needle aspiration technique does not causes cancer to spread, and undergoing a biopsy even improves mortality and overall survival.
This study does not only apply to those with pancreatic cancer as the fine needle aspiration technique is used across various tumor types.
Cancer biopsies do not cause cancer to spread.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Baseline PSA Levels in Midlife Could Predict Risk of Lethal Prostate Cancer
- Community Breast Navigation Program Improved Breast Screening Rates in Underserved African American and Latino Women
- Live-streamed Videos Address End-of-Life Planning, Decision-making
- Metastatic Disease Linked to Patients Reporting Diminished QoL
- History of Bilateral Salpingo-oophorectomy, Hormone Replacement Therapy Are Predictive of Breast Density at Cancer Diagnosis
- Mammographically Occult Contralateral Breast Cancer Detection is Effective With Preoperative MRI
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|